Literature DB >> 18846324

Construction, expression and in vitro biological effects of idiotype Ig Fab fragment of B-chronic lymphocytic leukemia.

Feng Wang1, Ping Lei, Ping Hu, Lijuan Zhu, Huifeng Zhu, Yue Zhang, Jing Yang, Guanxin Shen.   

Abstract

The purpose of this study was to construct expression vectors of idiotype (Id) SmIg in patients with B-chronic lymphocytic leukemia and to express them in E.coli to obtain recombinant Id, and to investigate the effect of the protein on the proliferation and secretion of IL-2 and IFN-gamma of stimulated peripheral blood mononuclear cells (PBMC) in vitro. Light chain gene and Fd fragment of heavy chain gene were inserted into fd-tet-DOG2 vector to construct fd-tet-DOG2-Fab. Fab gene was further cloned into expression vector pHEN2 to construct the soluble expression vector pHEN2-Fab. After induction by IPTG, Fab protein was purified by Ni-NTA-chromatography. MTT was used to determine the effects of purified protein on the proliferation of stimulated PBMC in vitro and the concentrations of IL-2 and IFN-gamma in the culture supernatants were detected by ELISA. The results showed that recombinant pHEN2-Fab expression vector was constructed successfully. Fab protein was expressed in positive clone after induced by IPTG and two specific bands at 24-25 kD position were observed by SDS-PAGE electrophoresis. Proliferation of PBMC could be induced by purified Fab and the concentrations of IL-2 and IFN-gamma in culture supernatants were increased significantly after induction. It was suggested that the expression vector of SmIg Fab fragment was constructed successfully, and expressed and secreted from E. coli. The Fab protein could induce proliferation of PBMC and promote secretion of IL-2 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846324     DOI: 10.1007/s11596-008-0501-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Chronic lymphocytic leukemia.

Authors:  Nicholas Chiorazzi; Kanti R Rai; Manlio Ferrarini
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

Review 2.  Immune defects in patients with chronic lymphocytic leukemia.

Authors:  Farhad Ravandi; Susan O'Brien
Journal:  Cancer Immunol Immunother       Date:  2005-07-16       Impact factor: 6.968

3.  Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy.

Authors:  Wen-Kai Weng; Debra Czerwinski; Ronald Levy
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

4.  Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.

Authors:  Maurizio Bendandi; Mercedes Rodríguez-Calvillo; Susana Inogés; Ascensión López-Díaz de Cerio; José Antonio Pérez-Simón; Arancha Rodríguez-Caballero; Andres García-Montero; Julia Almeida; Natalia Zabalegui; Pilar Giraldo; Jesús San Miguel; Alberto Orfao
Journal:  Leuk Lymphoma       Date:  2006-01

5.  Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.

Authors:  S S Neelapu; N C Munshi; S Jagannath; T M Watson; R Pennington; C Reynolds; B Barlogie; L W Kwak
Journal:  Bone Marrow Transplant       Date:  2005-08       Impact factor: 5.483

6.  Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.

Authors:  Cristina Bertinetti; Frederic Simon; Katja Zirlik; Kristina Heining-Mikesch; Dietmar Pfeifer; Frank Osterroth; Felicia M Rosenthal; Hendrik Veelken
Journal:  Eur J Haematol       Date:  2006-07-27       Impact factor: 2.997

7.  [Cloning of Ig Fab genes of patients with chronic B lymphocytic leukemia and sequences analysis of their variable regions].

Authors:  Huifen Zhu; Feng Wang; Yue Zhang; Guanxin Shen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2002-09

8.  Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.

Authors:  Sattva S Neelapu; Barry L Gause; Daniel A Nikcevich; Stephen J Schuster; Jane Winter; Jon P Gockerman; Thomas Loughran; Ken Takeshita; Giorgio Inghirami; Dean McGaughey; Thelma M Watson; Sandra Snow; Paula Kubovic; Miriam Ferraro; Elizabeth Jones; Elaine S Jaffe; Douglas J Schwartzentruber; David Danforth; Richard Sherry; Erik Kass; Carter Van Waes; Craig W Reynolds; Larry J Kwak
Journal:  Clin Lymphoma       Date:  2005-06

Review 9.  The role of idiotype vaccines in the treatment of human B-cell malignancies.

Authors:  Maurizio Bendandi
Journal:  Expert Rev Vaccines       Date:  2004-04       Impact factor: 5.217

Review 10.  Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphoma.

Authors:  Wei Ding; Clive S Zent
Journal:  Clin Adv Hematol Oncol       Date:  2007-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.